Biotechnology
New patent for the drug Chemocentryx TAVNEOS – DrugPatentWatch
[ad_1]
Copyright © DrugPatentWatch. Originally published in New Patent for TAVNEOS drug Chemocentryx
Annual Drug Patent Expiration for TAVNEOS
Tavneos is a drug marketed by Chemocentryx and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
This drug has fifty-one patent family members in thirty-two countries.
The generic ingredient in TAVNEOS is avacopan. One registered supplier for this compound. Additional details are available on the Avacopan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New Patent for TAVNEOS drug Chemocentryx
Related
[ad_2]
Source link
